A soluble form of fibroblast growth factor receptor 2 (FGFR2) with S252W mutation acts as an efficient inhibitor for the enhanced osteoblastic differentiation caused by FGFR2 activation in Apert syndrome
| Image |  |
|---|---|
| Description | scientific article published on 13 August 2004 |
| Author/s |
author: Toshio Matsumoto |
| Publication date | August 13, 2004 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |